Suppr超能文献

将暴露前预防付诸实践:从美国早期采用者提供艾滋病毒暴露前预防及相关护理的第一手经验中吸取的教训。

Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.

作者信息

Calabrese Sarah K, Magnus Manya, Mayer Kenneth H, Krakower Douglas S, Eldahan Adam I, Gaston Hawkins Lauren A, Hansen Nathan B, Kershaw Trace S, Underhill Kristen, Betancourt Joseph R, Dovidio John F

机构信息

Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT, United States of America.

Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, United States of America.

出版信息

PLoS One. 2016 Jun 15;11(6):e0157324. doi: 10.1371/journal.pone.0157324. eCollection 2016.

Abstract

Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource, requires expanding healthcare providers' adoption of PrEP into clinical practice. This qualitative study explored PrEP providers' firsthand experiences relative to six commonly-cited barriers to prescription-financial coverage, implementation logistics, eligibility determination, adherence concerns, side effects, and anticipated behavior change (risk compensation)-as well as their recommendations for training PrEP-inexperienced providers. U.S.-based PrEP providers were recruited via direct outreach and referral from colleagues and other participants (2014-2015). One-on-one interviews were conducted in person or by phone, transcribed, and analyzed. The sample (n = 18) primarily practiced in the Northeastern (67%) or Southern (22%) U.S. Nearly all (94%) were medical doctors (MDs), most of whom self-identified as infectious disease specialists. Prior experience prescribing PrEP ranged from 2 to 325 patients. Overall, providers reported favorable experiences with PrEP implementation and indicated that commonly anticipated problems were minimal or manageable. PrEP was covered via insurance or other programs for most patients; however, pre-authorization requirements, laboratory/service provision costs, and high deductibles sometimes presented challenges. Various models of PrEP care and coordination with other providers were utilized, with several providers highlighting the value of clinical staff support. Eligibility was determined through joint decision-making with patients; CDC guidelines were commonly referenced but not considered absolute. Patient adherence was variable, with particularly strong adherence noted among patients who had actively sought PrEP (self-referred). Providers observed minimal adverse effects or increases in risk behavior. However, they identified several barriers with respect to accessing and engaging PrEP candidates. Providers offered a wide range of suggestions regarding content, strategy, and logistics surrounding PrEP training, highlighting sexual history-taking and sexual minority competence as areas to prioritize. These insights from early-adopting PrEP providers may facilitate adoption of PrEP into clinical practice by PrEP-inexperienced providers, thereby improving access for individuals at risk for HIV.

摘要

优化获得艾滋病毒暴露前预防(PrEP)这一循证艾滋病毒预防资源的途径,需要扩大医疗服务提供者将PrEP纳入临床实践的比例。这项定性研究探讨了PrEP提供者在六个常被提及的障碍方面的亲身经历,这些障碍包括处方医保覆盖、实施后勤、资格判定、依从性问题、副作用以及预期行为改变(风险补偿),同时也探讨了他们对培训缺乏PrEP经验的提供者的建议。通过直接外联以及同事和其他参与者的推荐,招募了美国的PrEP提供者(2014 - 2015年)。进行了一对一的面对面或电话访谈,访谈内容进行了转录和分析。样本(n = 18)主要在美国东北部(67%)或南部(22%)执业。几乎所有(94%)都是医生(MD),其中大多数自称是传染病专家。之前开具PrEP处方的经验范围为2至325名患者。总体而言,提供者报告了PrEP实施方面的良好经验,并表示通常预期的问题很少或易于管理。大多数患者通过保险或其他项目获得PrEP覆盖;然而,预先授权要求、实验室/服务提供成本以及高额免赔额有时会带来挑战。采用了各种PrEP护理模式以及与其他提供者的协调方式,有几位提供者强调了临床工作人员支持的价值。资格通过与患者共同决策来确定;通常会参考美国疾病控制与预防中心(CDC)的指南,但并不认为是绝对的。患者的依从性各不相同,积极寻求PrEP(自我转诊)的患者中依从性特别强。提供者观察到不良反应或风险行为增加的情况很少。然而,他们确定了在接触和吸引PrEP候选者方面存在的几个障碍。提供者就PrEP培训的内容、策略和后勤方面提出了广泛的建议,强调将性史询问和性少数群体能力作为优先考虑的领域。这些来自早期采用PrEP的提供者的见解可能会促进缺乏PrEP经验的提供者将PrEP纳入临床实践,从而改善艾滋病毒高危个体的可及性。

相似文献

3
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28.
4
Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
AIDS Patient Care STDS. 2019 Feb;33(2):79-88. doi: 10.1089/apc.2018.0166.
5
Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
J Gen Intern Med. 2019 Apr;34(4):535-543. doi: 10.1007/s11606-019-04850-w. Epub 2019 Feb 4.
6
HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.
AIDS Care. 2016 Sep;28(9):1154-8. doi: 10.1080/09540121.2016.1153595. Epub 2016 Feb 26.
9
Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
J Womens Health (Larchmt). 2019 Sep;28(9):1272-1285. doi: 10.1089/jwh.2018.7353. Epub 2019 Jun 10.

引用本文的文献

1
HIV Preexposure Prophylaxis Service Delivery Models for Emergency Departments: A Qualitative Study.
J Int Assoc Provid AIDS Care. 2025 Jan-Dec;24:23259582251342842. doi: 10.1177/23259582251342842. Epub 2025 May 27.
3
Pre-Exposure Prophylaxis Awareness and Demand Creation: Overlooked Populations and Opportunities to Move Forward.
J Acquir Immune Defic Syndr. 2025 Apr 15;98(5S):e170-e180. doi: 10.1097/QAI.0000000000003626.
5
Determinants of Familiarity and Experience with HIV Pre-Exposure Prophylaxis in Primary Care Providers in Ontario, Canada.
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251315566. doi: 10.1177/21501319251315566.
7
Addressing Unmet PrEP Needs in Women: Impact of a Laboratory-Driven Protocol at an Urban, Essential Hospital.
Open Forum Infect Dis. 2024 Feb 1;11(3):ofae056. doi: 10.1093/ofid/ofae056. eCollection 2024 Mar.
8
Overcoming structural barriers to diffusion of HIV pre-exposure prophylaxis.
J Med Access. 2023 Dec 6;7:27550834231214958. doi: 10.1177/27550834231214958. eCollection 2023 Jan-Dec.

本文引用的文献

2
What people want from sex and preexposure prophylaxis.
Curr Opin HIV AIDS. 2016 Jan;11(1):3-9. doi: 10.1097/COH.0000000000000216.
3
The role of healthcare providers in the roll out of preexposure prophylaxis.
Curr Opin HIV AIDS. 2016 Jan;11(1):41-8. doi: 10.1097/COH.0000000000000206.
4
Diffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians.
Clin Infect Dis. 2016 Jan 1;62(1):99-105. doi: 10.1093/cid/civ736. Epub 2015 Sep 18.
5
The current status of the use of oral medication to prevent HIV transmission.
Curr Opin HIV AIDS. 2015 Jul;10(4):226-32. doi: 10.1097/COH.0000000000000170.
6
Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.
AIDS Patient Care STDS. 2015 Apr;29(4):193-203. doi: 10.1089/apc.2014.0273. Epub 2015 Feb 18.
7
PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives.
Subst Abuse Treat Prev Policy. 2015 Jan 8;10:1. doi: 10.1186/1747-597X-10-1.
8
Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.
AIDS Patient Care STDS. 2015 Feb;29(2):102-10. doi: 10.1089/apc.2014.0142. Epub 2014 Dec 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验